- Nearly 2 billion people may live with metabolic liver disease by 2050 globally
- Current cases of MASLD have surged to 1.3 billion, a 143% rise since 1990
- MASLD is linked to obesity, diabetes, sedentary lifestyles, and poor diets
A new Lancet global study has issued a stark warning: Nearly 2 billion people worldwide could be living with metabolic liver disease by 2050. The condition, now known as metabolic dysfunction-associated steatotic liver disease (MASLD), previously called non-alcoholic fatty liver disease, has quietly become one of the most common chronic liver disorders globally. According to findings published in The Lancet Gastroenterology & Hepatology, the number of people affected has already surged dramatically over the past three decades, driven largely by rising obesity rates, sedentary lifestyles, and increasing cases of type 2 diabetes. Today, an estimated 1.3 billion people are living with the disease, a figure projected to grow significantly in the coming decades.
What makes MASLD particularly concerning is that it often develops silently, without noticeable symptoms, until it progresses to severe complications such as liver cirrhosis or cancer. Health experts warn that without urgent public health interventions, this growing burden could overwhelm healthcare systems worldwide.
Understanding what MASLD is, why it is rising so rapidly, and how it can be prevented is essential to tackling what is increasingly being described as a global metabolic health crisis.
What Is Metabolic Liver Disease?
Metabolic dysfunction-associated steatotic liver disease (MASLD) occurs when excess fat accumulates in the liver due to underlying metabolic issues such as obesity, insulin resistance, and diabetes.
According to clinical research, MASLD is now one of the most common forms of chronic liver disease worldwide, affecting up to 25-30% of adults globally.
It is part of a broader spectrum of metabolic disorders and is closely linked to conditions like:
- Type 2 diabetes
- High blood pressure
- Obesity
- High cholesterol
The disease can progress from simple fat accumulation to inflammation (steatohepatitis), fibrosis, cirrhosis, and even liver cancer if left untreated.
Also Read: Gastroenterologist Explains How Drinking Methi Water Every Morning Can Benefit Grade-1 Fatty Liver
The Alarming Numbers: What The Study Found
The latest analysis from the Global Burden of Disease (GBD) study paints a worrying picture of the future.
Key findings include:
- Around 1.3 billion people currently live with MASLD globally
- This represents a 143% increase since 1990
- By 2050, cases could rise to 1.8 billion, or nearly 1 in 5 people worldwide
The study attributes this surge primarily to:
- Rising obesity rates
- Increasing blood sugar levels
- Sedentary lifestyles
Importantly, while more people are developing the disease, improved early detection and care may be helping reduce severe outcomes for now.
Why Is MASLD Increasing So Rapidly?
The rise of MASLD is closely tied to what experts call the "metabolic epidemic." High blood sugar levels were identified as the leading contributor to disease burden, followed by high body mass index (BMI) and smoking. (ajmc.com)
Urbanisation, dietary shifts toward processed and high-calorie foods, and reduced physical activity are major drivers. In countries undergoing rapid economic transition, including India, the risk is particularly high. Additionally, the study highlights a worrying trend that MASLD is increasingly affecting younger adults, not just older populations.
A Silent Disease With Serious Consequences
One of the biggest challenges with MASLD is that it often shows no symptoms in its early stages. According to clinical data:
- Many people remain undiagnosed for years
- Symptoms, if present, may include fatigue or mild abdominal discomfort
- Severe complications may develop silently
If untreated, MASLD can progress to:
- Liver fibrosis (scarring)
- Cirrhosis
- Liver failure
- Liver cancer
It is already a leading cause of end-stage liver disease and liver transplantation in several regions.
Who Is Most At Risk?
The condition is more common in:
- People with obesity
- Individuals with type 2 diabetes
- Those with high cholesterol or metabolic syndrome
Men tend to have higher prevalence overall, though older women may face higher complication risks. Geographically, regions such as North Africa and the Middle East currently show the highest prevalence, but cases are rising globally, including in South Asia.
Can It Be Prevented Or Reversed?
The good news is that MASLD is often preventable, and even reversible in early stages. Health experts recommend:
- Maintaining a healthy weight
- Regular physical activity
- Controlling blood sugar levels
- Eating a balanced, low-processed diet
Research shows that even modest weight loss can significantly reduce liver fat and inflammation. However, experts caution that there are currently limited approved medications specifically for MASLD, making lifestyle changes the cornerstone of treatment.
Also Read: Diabetes And Fatty Liver Disease: The Role Of Insulin Resistance Explained
A Growing Public Health Priority
Despite its rising burden, MASLD is still under-recognised in global health policies.
The study authors stress the need for:
- Increased screening programs
- Public awareness campaigns
- Integration into non-communicable disease strategies
Without timely action, the condition could lead to a surge in advanced liver disease cases in the coming decades. The projection that nearly 2 billion people could be affected by metabolic liver disease by 2050 highlights a looming global health crisis. Driven by lifestyle changes and metabolic disorders, MASLD is rapidly becoming one of the most significant threats to liver health worldwide. While the disease often develops silently, its long-term consequences can be severe. The key to reversing this trend lies in early detection, lifestyle interventions, and stronger public health policies. As experts warn, tackling MASLD is not just about liver health, it is central to addressing the broader global epidemic of metabolic disease.
Disclaimer: This content, including advice, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.
